Product Program year 2025 Source: CMS Open Payments

OsteoStrand

Device OrthoBiologics

Open in the dashboard

General payments

$339,278

178 payments

Research payments

$146,338

51 payments

Through program year 2025, $339,278 in general payments and $146,338 in research payments were reported against OsteoStrand (OrthoBiologics).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

10 rows
Year Kind Amount Payments
2025 General $1,292 16
2024 General $81,183 17
2023 General $117,509 33
2022 General $20,866 12
2021 General $17,371 21
2021 Research $10,165 4
2020 General $29,029 21
2020 Research $81,444 30
2019 General $72,029 58
2019 Research $54,729 17

Breakdown

Who paid General payments · program years 2019–2025
  1. Orthofix Medical, Inc. $199,983 66 payments
  2. Seaspine Orthopedics Corporation $139,295 112 payments
Top recipients General payments · program year 2025
  1. Joshua Wewel Neurological Surgery · Atlanta, GA $161 12% · 1 payment
  2. Emily Mills Orthopaedic Surgery of the Spine · Orange, CA $159 12% · 2 payments
  3. Michael Spitnale Orthopaedic Surgery of the Spine · Columbia, SC $148 11% · 1 payment
  4. Hao-Hua Wu Orthopaedic Surgery of the Spine · Orange, CA $134 10% · 1 payment
  5. Erik Spayde Orthopaedic Surgery · Thousand Oaks, CA $126 10% · 2 payments

The top 5 of 12 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Orthopaedic Surgery of the Spine Orthopaedic Surgery $674 52% · 7 practitioners
  2. Neurological Surgery $492 38% · 4 practitioners
  3. Orthopaedic Surgery $126 10% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. California $708 55% · 7 recipients
  2. Georgia $161 12% · 1 recipient
  3. Pennsylvania $148 11% · 1 recipient
  4. Kentucky $117 9% · 1 recipient
  5. Massachusetts $110 9% · 1 recipient

The top 5 of 6 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

178 general · 51 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record